Analyst firms · Leerink Partners · AMED
Leerink Partners AMED price target and rating history
Amedisys Inc (AMED) · Health Care
Leerink Partners rates Amedisys Inc (AMED) Market Perform with a $147 price target, as of its latest action on Feb 18, 2022. It has published 3 rating actions on AMED since September 2021, including 0 upgrades and 0 downgrades.
- Current rating
- Market Perform
- Price target
- $147
- Median target, all firms
- Too few
- Actions on AMED
- 3
Leerink Partners price target on AMED
Every Leerink Partners rating on AMED
- Feb 18, 2022
- Nov 4, 2021
- Sep 27, 2021
Questions about Leerink Partners and AMED
- What is Leerink Partners's price target for AMED?
- Leerink Partners's latest stated price target for Amedisys Inc (AMED) is $147, from its action on Feb 18, 2022.
- What is Leerink Partners's rating on AMED?
- Leerink Partners rates AMED Market Perform, a neutral rating, as of Feb 18, 2022.
- When did Leerink Partners last change its view on AMED?
- On Feb 18, 2022, Leerink Partners raises its price target to $147 from $145, keeps Market Perform.
More AMED rating histories
All Leerink Partners ratingsAMED news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.